215 related articles for article (PubMed ID: 38529274)
21. Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis.
Ou B; Zhao J; Guan S; Lu A
Dig Dis Sci; 2016 Mar; 61(3):881-9. PubMed ID: 26518415
[TBL] [Abstract][Full Text] [Related]
22. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
[TBL] [Abstract][Full Text] [Related]
23. The actin-cytoskeleton pathway and its potential role in inflammatory bowel disease-associated human colorectal cancer.
Kanaan Z; Qadan M; Eichenberger MR; Galandiuk S
Genet Test Mol Biomarkers; 2010 Jun; 14(3):347-53. PubMed ID: 20406101
[TBL] [Abstract][Full Text] [Related]
24. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
25. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
Du L; Kim JJ; Shen J; Chen B; Dai N
Oncotarget; 2017 Mar; 8(13):22175-22186. PubMed ID: 28077799
[TBL] [Abstract][Full Text] [Related]
26. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
Kim ER; Chang DK
World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418
[TBL] [Abstract][Full Text] [Related]
27. Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer.
Schottelius AJ; Dinter H
Cancer Treat Res; 2006; 130():67-87. PubMed ID: 16610703
[TBL] [Abstract][Full Text] [Related]
28. Temporal trend in inpatient mortality in inflammatory bowel disease-associated colorectal cancer vs non-inflammatory colorectal cancer: a nationwide retrospective study.
Flores E; Mbachi C; Achebe I; Asotibe J; Palomera-Tejeda E; Vohra I; Udechukwu V; Kotwal V
Int J Colorectal Dis; 2021 Apr; 36(4):701-708. PubMed ID: 33063223
[TBL] [Abstract][Full Text] [Related]
29. Molecular and cellular pathways in colorectal cancer: apoptosis, autophagy and inflammation as key players.
Yu L; Zhang MM; Hou JG
Scand J Gastroenterol; 2022 Nov; 57(11):1279-1290. PubMed ID: 35732586
[TBL] [Abstract][Full Text] [Related]
30. Role of epigenetics in transformation of inflammation into colorectal cancer.
Yang ZH; Dang YQ; Ji G
World J Gastroenterol; 2019 Jun; 25(23):2863-2877. PubMed ID: 31249445
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
32. Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis.
Li H; Jin Z; Li X; Wu L; Jin J
Clin Transl Oncol; 2017 Aug; 19(8):1018-1027. PubMed ID: 28243990
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer.
Laurent C; Svrcek M; Flejou JF; Chenard MP; Duclos B; Freund JN; Reimund JM
Inflamm Bowel Dis; 2011 Jan; 17(1):232-40. PubMed ID: 20815042
[TBL] [Abstract][Full Text] [Related]
34. Whole blood ACTB, B2M and GAPDH expression reflects activity of inflammatory bowel disease, advancement of colorectal cancer, and correlates with circulating inflammatory and angiogenic factors: Relevance for real-time quantitative PCR.
Bednarz-Misa I; Neubauer K; Zacharska E; Kapturkiewicz B; Krzystek-Korpacka M
Adv Clin Exp Med; 2020 May; 29(5):547-556. PubMed ID: 32424999
[TBL] [Abstract][Full Text] [Related]
35. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
Bhat AA; Nisar S; Singh M; Ashraf B; Masoodi T; Prasad CP; Sharma A; Maacha S; Karedath T; Hashem S; Yasin SB; Bagga P; Reddy R; Frennaux MP; Uddin S; Dhawan P; Haris M; Macha MA
Cancer Commun (Lond); 2022 Aug; 42(8):689-715. PubMed ID: 35791509
[TBL] [Abstract][Full Text] [Related]
36. Interrelations of Apoptotic and Cellular Senescence Genes Methylation in Inflammatory Bowel Disease Subtypes and Colorectal Carcinoma in Egyptians Patients.
Salama RH; Sayed ZEA; Ashmawy AM; Elsewify WA; Ezzat GM; Mahmoud MA; Alsanory AA; Alsanory TA
Appl Biochem Biotechnol; 2019 Sep; 189(1):330-343. PubMed ID: 30989570
[TBL] [Abstract][Full Text] [Related]
37. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
Peng Z; Ye M; Ding H; Feng Z; Hu K
J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer-inflammatory bowel disease nexus and felony of Escherichia coli.
Khan AA; Khan Z; Malik A; Kalam MA; Cash P; Ashraf MT; Alshamsan A
Life Sci; 2017 Jul; 180():60-67. PubMed ID: 28506682
[TBL] [Abstract][Full Text] [Related]
39. Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.
Motilva V; Talero E; Calvo JR; Villegas I; Alarcón-de-la-Lastra C; Sánchez-Fidalgo S
Curr Pharm Des; 2008; 14(1):71-95. PubMed ID: 18220820
[TBL] [Abstract][Full Text] [Related]
40. MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner.
Deng S; Cheng D; Wang J; Gu J; Xue Y; Jiang Z; Qin L; Mao F; Cao Y; Cai K
J Exp Clin Cancer Res; 2023 Nov; 42(1):294. PubMed ID: 37926835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
